AOTI, Inc. (AOTI.L)

LSE • Market Data in GBP, Fundamentals in USD Market GBP / Fundamentals USD

£90.00

-£3.00

-3.33%

Last Update: 16 Jul 2025, 15:35

£95.72M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

£75.00 - £135.19

52 Week Range

AOTI.L Stock Price Chart

Explore AOTI, Inc. interactive price chart. Choose custom timeframes to analyze AOTI.L price movements and trends.

There is nothing to show.

AOTI.L Company Profile

Discover essential business fundamentals and corporate details for AOTI, Inc. (AOTI.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Specialties

IPO Date

18 Jun 2024

Employees

85.00

Website

http://aotinc.net

CEO

Michael Griffiths CRT, DMS

Description

AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. Its products include the Topical Wound Oxygen (TWO2) Therapy and the NEXA NPWT (negative pressure wound therapy) System. The company was founded by Michael Stephen Griffiths in 2006 and is headquartered in Oceanside, CA.

AOTI.L Financial Timeline

Browse a chronological timeline of AOTI, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 28 Apr 2025

Earnings released on 16 Sept 2024

EPS came in at -£0.04, while revenue for the quarter reached £20.83M, beating expectations by +0.15%.

Earnings released on 30 Jun 2024

EPS came in at -£0.00, while revenue for the quarter reached £3.48M.

Earnings released on 30 Jun 2023

EPS came in at -£0.00, while revenue for the quarter reached £2.99M.

AOTI.L Stock Performance

Access detailed AOTI.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.